Pharmacological IRS1/2 Inhibition Reduces Cell Viability in BCR-ABL1 Positive Cells

被引：0
|
作者：
Scopim-Ribeiro, Renata [1 ]
Machado-Neto, Joao Agostinho [1 ]
Campos, Paula de Melo [2 ]
Santos Duarte, Adriana da Silva [2 ]
Scheucher, Priscila Santos [1 ]
Goes, Amelia [1 ]
Olalla Saad, Sara Teresinha [2 ]
Simoes, Belinda Pinto [1 ]
Rego, Eduardo Magalhaes [1 ]
Traina, Fabiola [1 ]
机构：
[1] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Internal Med, BR-14049 Ribeirao Preto, Brazil
[2] Univ Estadual Campinas, Inst Nacl Ciencia & Tecnol Sangue, Hematol & Hemotherapy Ctr, Campinas, SP, Brazil
来源：
BLOOD | 2015年 / 126卷 / 23期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Reversibility of acute B-cell leukaemia induced by BCR-ABL1
    Huettner, CS
    Zhang, P
    Van Etten, RA
    Tenen, DG
    NATURE GENETICS, 2000, 24 (01) : 57 - 60
  • [22] BCR-ABL1 expression in multiple myeloma cells: A case of mistaken identity?
    MacLeod, Roderick A. F.
    Nagel, Stefan
    Dirks, Wilhelm
    Drexler, Hans G.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2013, 110 (04) : E270 - E271
  • [23] Allosteric enhancement of the BCR-Abl1 kinase inhibition activity of nilotinib by cobinding of asciminib
    Oruganti, Baswanth
    Lindahl, Erik
    Yang, Jingmei
    Amiri, Wahid
    Rahimullah, Rezwan
    Friedman, Ran
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2022, 298 (08)
  • [24] Evolution of human BCR-ABL1 lymphoblastic leukaemia-initiating cells
    Notta, Faiyaz
    Mullighan, Charles G.
    Wang, Jean C. Y.
    Poeppl, Armando
    Doulatov, Sergei
    Phillips, Letha A.
    Ma, Jing
    Minden, Mark D.
    Downing, James R.
    Dick, John E.
    NATURE, 2011, 469 (7330) : 362 - +
  • [25] In BCR-ABL1 Positive B-Cell Acute Lymphoblastic Leukemia, Steroid Therapy Induces Hypofibrinogenemia
    Buzzatti, Elisa
    Forghieri, Fabio
    Paterno, Giovangiacinto
    Marchesi, Francesco
    Sarlo, Chiara
    Giglio, Fabio
    Fracchiolla, Nicola
    Sciume, Mariarita
    Palmieri, Raffaele
    Esposito, Fabiana
    Guarnera, Luca
    Mercante, Lisa
    Pascale, Maria Rosaria
    Mallegni, Flavia
    Savi, Arianna
    Forte, Vittorio
    Maurillo, Luca
    Buccisano, Francesco
    Venditti, Adriano
    Del Principe, Maria Ilaria
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (07)
  • [26] Coordinated inhibition of nuclear export and Bcr-Abl1 selectively targets chronic myeloid leukemia stem cells
    Than, Hein
    Pomicter, Anthony D.
    Yan, Dongqing
    Beaver, Larry P.
    Eiring, Anna M.
    Heaton, William L.
    Senina, Anna
    Clair, Phillip M.
    Shacham, Sharon
    Mason, Clinton C.
    O'Hare, Thomas
    Deininger, Michael W.
    LEUKEMIA, 2020, 34 (06) : 1679 - 1683
  • [27] T-Cell acute lymphoblastic leukemia with a pinch of BCR-ABL1
    Cortes, Jorge
    De Keersmaecker, Kim
    LEUKEMIA & LYMPHOMA, 2009, 50 (03) : 321 - 322
  • [28] Coordinated inhibition of nuclear export and Bcr-Abl1 selectively targets chronic myeloid leukemia stem cells
    Hein Than
    Anthony D. Pomicter
    Dongqing Yan
    Larry P. Beaver
    Anna M. Eiring
    William L. Heaton
    Anna Senina
    Phillip M. Clair
    Sharon Shacham
    Clinton C. Mason
    Thomas O’ Hare
    Michael W. Deininger
    Leukemia, 2020, 34 : 1679 - 1683
  • [29] Impact of timely BCR-ABL1 monitoring before allogeneic stem cell transplantation among patients with BCR-ABL1-positive B-acute lymphoblastic leukemia
    Chong, Siew Lian
    Asnawi, Asral Wirda Ahmad
    Leong, Tze Shin
    Tan, Jenq Tzong
    Law, Kian Boon
    Hon, Siong Leng
    Fann, Rui Jeat
    Tan, Sen Mui
    BLOOD RESEARCH, 2021, 56 (03) : 175 - 183
  • [30] c-Myc inhibition decreases CIP2A and reduces BCR-ABL1 tyrosine kinase activity in chronic myeloid leukemia
    Lucas, Claire M.
    Harris, Robert J.
    Giannoudis, Athina
    Clark, Richard E.
    HAEMATOLOGICA, 2015, 100 (05)
12345